• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射类固醇治疗难治性化疗相关性腹泻:一例报告

Intravenous Steroids for Refractory Chemotherapy-Related Diarrhea: A Case Report.

作者信息

Patel Kishan, Dang Adrian, Makhlouf Mai M, Raman Alex G, Abdulla Nihal E

机构信息

College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, USA.

Department of Oncology, Los Alamitos Medical Center, Los Alamitos, USA.

出版信息

Cureus. 2023 Feb 4;15(2):e34634. doi: 10.7759/cureus.34634. eCollection 2023 Feb.

DOI:10.7759/cureus.34634
PMID:36895532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9989110/
Abstract

The clinical course of a patient with chemotherapy-related diarrhea (CRD) refractory to standard therapy was monitored over the course of 21 days. The patient was minimally responsive to traditional treatment options, including bismuth subsalicylate, diphenoxylate-atropine, loperamide, octreotide, and oral (PO) steroids, and exhibited reportable improvements with the addition of intravenous (IV) methylprednisolone to other antidiarrheal agents. We present a case of CRD in an 82-year-old female. She was initiated on chemotherapy three weeks prior and has experienced severe diarrhea since her initiation. Despite the use of first-line antidiarrheal therapies, including loperamide, diphenoxylate-atropine, and octreotide, both subcutaneously and via continuous infusion drip, no infectious cause was found. She also received the non-absorbing corticosteroid budesonide, but her diarrhea persisted. After experiencing severe hypotension and hypovolemia secondary to profuse diarrhea, she was placed on IV steroids, which quickly reduced her symptoms. The patient was then transitioned to oral steroids and discharged on a tapering regimen. We recommend using IV steroids to treat CRD if first-line therapies fail. Utilizing IV steroids efficiently and effectively can decrease the symptoms of persistent diarrhea and lead to rapid recovery.

摘要

在21天的时间里对一名化疗相关腹泻(CRD)患者的临床病程进行了监测,该患者对标准治疗无效。患者对包括次水杨酸铋、地芬诺酯-阿托品、洛哌丁胺、奥曲肽和口服(PO)类固醇在内的传统治疗选择反应甚微,在其他止泻药物中添加静脉注射(IV)甲泼尼龙后症状有所改善。我们报告一例82岁女性的CRD病例。她在三周前开始化疗,自化疗开始后就出现严重腹泻。尽管使用了一线止泻疗法,包括皮下注射和持续静脉滴注洛哌丁胺、地芬诺酯-阿托品和奥曲肽,但未发现感染原因。她还接受了不吸收的皮质类固醇布地奈德治疗,但腹泻仍持续。在经历了因大量腹泻导致的严重低血压和血容量不足后,她接受了静脉注射类固醇治疗,症状迅速减轻。随后患者转为口服类固醇,并以逐渐减量的方案出院。我们建议,如果一线治疗失败,可使用静脉注射类固醇治疗CRD。有效且高效地使用静脉注射类固醇可以减轻持续性腹泻的症状并促进快速康复。

相似文献

1
Intravenous Steroids for Refractory Chemotherapy-Related Diarrhea: A Case Report.静脉注射类固醇治疗难治性化疗相关性腹泻:一例报告
Cureus. 2023 Feb 4;15(2):e34634. doi: 10.7759/cureus.34634. eCollection 2023 Feb.
2
Delayed Presentation of DPD Deficiency in Colorectal Cancer.结直肠癌中DPD缺乏的延迟表现
J Adv Pract Oncol. 2014 May;5(3):205-10. doi: 10.6004/jadpro.2014.5.3.5.
3
Palliative Chemotherapy: Does It Only Provide False Hope? The Role of Palliative Care in a Young Patient With Newly Diagnosed Metastatic Adenocarcinoma.姑息性化疗:它只是提供虚假希望吗?姑息治疗在一名新诊断为转移性腺癌的年轻患者中的作用。
J Adv Pract Oncol. 2017 May-Jun;8(4):382-386. Epub 2017 May 1.
4
Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.长效奥曲肽治疗癌症患者难治性化疗所致腹泻(CID):11例病例研究
Support Care Cancer. 2004 Aug;12(8):561-70. doi: 10.1007/s00520-003-0507-z. Epub 2004 May 25.
5
Control of irinotecan-induced diarrhea by octreotide after loperamide failure.在洛哌丁胺治疗失败后,奥曲肽对伊立替康所致腹泻的控制作用
Support Care Cancer. 2001 Jun;9(4):258-60. doi: 10.1007/s005200000220.
6
Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma.肠道休息、静脉补液以及持续高剂量输注醋酸奥曲肽用于治疗结直肠癌患者化疗引起的腹泻。
Cancer. 1993 Sep 1;72(5):1543-6. doi: 10.1002/1097-0142(19930901)72:5<1543::aid-cncr2820720509>3.0.co;2-z.
7
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy.皮下注射奥曲肽与口服洛哌丁胺治疗化疗后腹泻的对比
Anticancer Drugs. 1993 Aug;4(4):443-5. doi: 10.1097/00001813-199308000-00004.
8
Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial.奥曲肽治疗大量难治性艾滋病相关性腹泻:一项随机对照试验。
AIDS. 1994 Nov;8(11):1563-7. doi: 10.1097/00002030-199411000-00007.
9
Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.奥曲肽用于治疗直肠癌患者中对洛哌丁胺难治的放化疗引起的腹泻。
Oncology. 2006;71(5-6):354-60. doi: 10.1159/000108593. Epub 2007 Sep 17.
10
Management of acute cancer treatment-induced diarrhea.急性癌症治疗引起的腹泻的管理。
Semin Oncol Nurs. 2003 Nov;19(4 Suppl 3):11-6. doi: 10.1053/j.soncn.2003.09.009.

本文引用的文献

1
A Case of Unremitting Diarrhea.
Gastroenterology. 2020 Jan;158(1):62-64. doi: 10.1053/j.gastro.2019.05.070. Epub 2019 Jun 14.
2
Substantial activity of budesonide in patients with irinotecan (CPT-11) and 5-fluorouracil induced diarrhea and failure of loperamide treatment.布地奈德对伊立替康(CPT - 11)和5 - 氟尿嘧啶所致腹泻且洛哌丁胺治疗无效的患者有显著疗效。
Ann Oncol. 1999 Oct;10(10):1251-3. doi: 10.1023/a:1008390308416.
3
Recommended guidelines for the treatment of chemotherapy-induced diarrhea.
J Clin Oncol. 1998 Sep;16(9):3169-78. doi: 10.1200/JCO.1998.16.9.3169.